Herrmann, H., Cerny-Reiterer, S., Gleixner, K. V., Blatt, K., Herndlhofer, S., Rabitsch, W., Jäger, E., Mitterbauer-Hohendanner, G., Streubel, B., Selzer, E., Schwarzinger, I., Sperr, W. R. and Valent, P. (2012) “CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin”, Haematologica. Pavia, Italy, 97(2), pp. 219-226. doi: 10.3324/haematol.2010.035006.